Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 9, Pages 1211-1223
Publisher
Informa Healthcare
Online
2014-05-21
DOI
10.1517/13543784.2014.921680
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
- (2014) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Regression of Hodgkin Lymphoma in Response to Antiviral Therapy for Hepatitis C Virus Infection
- (2014) Ken Takahashi et al. INTERNAL MEDICINE
- Meeting report: 26th International Conference on Antiviral Research
- (2013) R. Anthony Vere Hodge ANTIVIRAL RESEARCH
- Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C
- (2013) Evangelista Sagnelli et al. Clinical Gastroenterology and Hepatology
- Novel Therapeutic Approaches for Hepatitis C
- (2013) J S Au et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir
- (2013) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection
- (2013) N. Coppola et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature
- (2013) Ferdinando Fusco et al. EXPERT OPINION ON PHARMACOTHERAPY
- Hepatitis C therapy with HCV NS5B polymerase inhibitors
- (2013) Vincent Soriano et al. EXPERT OPINION ON PHARMACOTHERAPY
- Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies
- (2013) Jianmeng Chen et al. GASTROENTEROLOGY
- A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C
- (2013) Ivan Gentile et al. Hepatitis Monthly
- Concordance between sustained virologic response week 12 (SVR12) and SVR24 in genotype 1 hepatitis C virus patients receiving interferon-free treatment in the SOUND-C2 study
- (2013) Stefan Zeuzem et al. HEPATOLOGY
- Association of tattooing and hepatitis C virus infection: A multicenter case-control study
- (2013) Kerrilynn Carney et al. HEPATOLOGY
- JUMP-C: A randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients
- (2013) Paul J. Pockros et al. HEPATOLOGY
- PROPEL: A randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients
- (2013) Heiner Wedemeyer et al. HEPATOLOGY
- Age and Gender Distribution of Hepatitis C Virus Genotypes in the Metropolitan Area of Naples
- (2013) Arnolfo Petruzziello et al. INTERVIROLOGY
- Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells
- (2013) Nicola Coppola et al. JOURNAL OF CLINICAL VIROLOGY
- 1222 IN VITRO RESISTANCE TO ALS-2200, A POTENT NUCLEOTIDE POLYMERASE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS C
- (2013) H. Tan et al. JOURNAL OF HEPATOLOGY
- 1219 VX-135, A POTENT SINGLE DIASTEREOMER OF ALS-2200, FOR THE TREATMENT OF CHRONIC HEPATITIS C
- (2013) H. Tan et al. JOURNAL OF HEPATOLOGY
- 1228 HepDirect™ IMPROVES LIVER-TARGETING OF HCV NUCLEOTIDE NS5B POLYMERASE INHIBITOR LG-7501 VERSUS PHOSPHORAMIDATE PRONUCLEOTIDE TECHNOLOGY
- (2013) E.G. Vajda et al. JOURNAL OF HEPATOLOGY
- In Vivo Emergence of a Novel Mutant L159F/L320F in the NS5B Polymerase Confers Low-Level Resistance to the HCV Polymerase Inhibitors Mericitabine and Sofosbuvir
- (2013) Xiao Tong et al. JOURNAL OF INFECTIOUS DISEASES
- Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C
- (2013) R. Zampino et al. JOURNAL OF VIRAL HEPATITIS
- All-oral therapy with nucleotide inhibitors sofosbuvir and GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (NUCLEAR)
- (2013) E. J. Lawitz et al. JOURNAL OF VIRAL HEPATITIS
- All-oral HCV therapies near approval
- (2013) Man Tsuey Tse NATURE REVIEWS DRUG DISCOVERY
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained virological response: A milestone in the treatment of chronic hepatitis C
- (2013) Filomena Morisco WORLD JOURNAL OF GASTROENTEROLOGY
- Characterization of Hepatitis C Virus (HCV) Quasispecies Dynamics upon Short-Term Dual Therapy with the HCV NS5B Nucleoside Polymerase Inhibitor Mericitabine and the NS3/4 Protease Inhibitor Danoprevir
- (2012) S. Le Pogam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Natural history of acute and chronic hepatitis C
- (2012) Benjamin Maasoumy et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
- (2012) Nicola Coppola et al. BMC INFECTIOUS DISEASES
- Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: Evidence for a vanishing infection
- (2012) Vincenzo Guadagnino et al. DIGESTIVE AND LIVER DISEASE
- TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury
- (2012) Sergio Duarte et al. HEPATOLOGY
- High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials
- (2012) Patrick Marcellin et al. HEPATOLOGY
- 1200 ANTIVIRAL ACTIVITY OF EP-NI266, A POTENT NUCLEOTIDE HCV POLYMERASE INHIBITOR
- (2012) C.M. Owens et al. JOURNAL OF HEPATOLOGY
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses
- (2012) Jean-Luc Raoul et al. JOURNAL OF HEPATOLOGY
- Perspectives and challenges of interferon-free therapy for chronic hepatitis C
- (2012) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients
- (2012) Assy Nimer WORLD JOURNAL OF GASTROENTEROLOGY
- INX-08189, a Phosphoramidate Prodrug of 6-O-Methyl-2′-C-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties
- (2011) John H. Vernachio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy
- (2011) Nicola Coppola et al. DIGESTIVE AND LIVER DISEASE
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)
- (2011) Jeremie Guedj et al. HEPATOLOGY
- 1198 NUCLEOTIDE INHIBITOR RESISTANCE SELECTIONS USING GT2A INFECTIOUS VIRUS: PSI-7851 AND GS-6620 SELECT FOR A NOVEL RESISTANCE PATHWAY INCLUDING SUBSTITUTIONS OF M289V/L FOLLOWED BY S282T
- (2011) G. Cheng et al. JOURNAL OF HEPATOLOGY
- 460 A STUDY OF THE SAFETY AND PHARMACOKINETICS OF SINGLE ASCENDING ORAL DOSES OF INX-08189, A NUCLEOTIDE POLYMERASE INHIBITOR, IN HEALTHY SUBJECTS
- (2011) J. Patti et al. JOURNAL OF HEPATOLOGY
- 1233 GS-6620: A LIVER TARGETED NUCLEOTIDE PRODRUG WITH POTENT PAN-GENOTYPE ANTI-HEPATITIS C VIRUS ACTIVITY IN VITRO
- (2011) A.S. Ray et al. JOURNAL OF HEPATOLOGY
- Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients
- (2011) Saif Abu-Mouch WORLD JOURNAL OF GASTROENTEROLOGY
- Anti-HCV drugs in the pipeline
- (2011) Priscilla L Yang et al. Current Opinion in Virology
- Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus
- (2010) Christopher McGuigan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Evolving epidemiology of hepatitis C virus
- (2010) D. Lavanchy CLINICAL MICROBIOLOGY AND INFECTION
- New NS5B polymerase inhibitors for hepatitis C
- (2010) Florence Legrand-Abravanel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Surrogate endpoints and non-inferiority trials in chronic viral hepatitis
- (2010) Ivan Gentile et al. JOURNAL OF HEPATOLOGY
- Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
- (2010) Christian Markus Lange et al. JOURNAL OF HEPATOLOGY
- RG7128 Alone or in Combination with Pegylated Interferon‐α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV‐Infected Patients
- (2010) Sophie Le Pogam et al. JOURNAL OF INFECTIOUS DISEASES
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Homocysteine levels and sustained virological response to pegylated-interferon α2b plus ribavirin therapy for chronic hepatitis C: a prospective study
- (2010) Guglielmo Borgia et al. LIVER INTERNATIONAL
- Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2009) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virus
- (2009) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- (2009) Gary L. Davis et al. GASTROENTEROLOGY
- Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial
- (2009) Ivan Gentile et al. JOURNAL OF CLINICAL APHERESIS
- Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index
- (2009) Nicola Coppola et al. JOURNAL OF CLINICAL VIROLOGY
- Different Incorporation Efficiencies for Nucleotide Analogs During HCV Polymerase RNA Synthesis Initiation and Elongation Phases
- (2008) Han Ma et al. ANTIVIRAL RESEARCH
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- A Simple Noninvasive Score Predicts Gastroesophageal Varices in Patients With Chronic Viral Hepatitis
- (2008) Ivan Gentile et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- 66 POTENT ANTIVIRAL ACTIVITY OF THE HCV NUCLEOSIDE POLYMERASE INHIBITOR R7128 WITH PEG-IFN AND RIBAVIRIN: INTERIM RESULTS OF R7128 500MG BID FOR 28 DAYS
- (2008) J. Lalezari et al. JOURNAL OF HEPATOLOGY
- Multiple Sclerosis and Hepatitis C Virus Infection Are Associated with Single Nucleotide Polymorphisms in Interferon Pathway Genes
- (2008) Giuliana Fortunato et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now